therapy has increased worldwide. Since this is a chronic treatment, patients receiving it can
be expected to need some kind of surgery or intervention during their lifetime that may
require treatment discontinuation. The decision to withdraw antithrombotic therapy depends
on the patient's thrombotic risk versus hemorrhagic risk. Assessment of both factors will
show the precise management of anticoagulant and antiplatelet therapy in these scenarios …